Startups
Contraline
Develops reversible male contraceptives. Its pipeline includes NES/T, an investigational daily topical hormonal gel designed to suppress sperm production, and ADAM, an investigational long-lasting non-hormonal implant. The company is advancing NES/T toward Phase 3 development following a completed Phase 2b study.
Team
Aaron SpitzScientific Advisory Board Member |
Amy WallsLab Technician |
Bethany YoungPrincipal Engineer |
Charlie BirdController |
Craig NiederbergerScientific Advisory Board Member |
Ella StackClinical Trial Manager |
Gurdane BhutaniBoard Director |
Iris van Alderwerelt van RosenburghBoard Director |
James TursiChief Scientific Officer |
Jay SandlowScientific Advisory Board Member |
John HerrCo-Founder (deceased in 2016) |
John KimVP, Regulatory Affairs |
Justin MatticeChief Commercial Officer |
Katie LloydDirector of Operations |
Kevin EisenfratsCo-Founder and CEO and Board Director |
Kyle RipleyOperations Manager |
Laila CampbellAssociate Engineer |
Lindsey OttDirector of Program Management |
 Marty EmersonBoard Director |
Meng DengScientific Advisory Board Member |
Nic MatsumotoDirector of Research |
Olivia LuuR&D Engineer |
Ria AgrawalR&D Engineer |
Robert GoldmanVP, Global Clinical Operations |
Robert GreenleafVP, Quality and Operations |
Ted LooneySr. Director of Finance and Business Development |
Tyler ChiartasAssociate Director, Preclinical Studies |
Yelena TropshaChief Technology Officer |